A detailed history of Capital Investment Advisory Services, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 17,874 shares of SAVA stock, worth $452,927. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,874
Previous 20,400 12.38%
Holding current value
$452,927
Previous $251,000 109.56%
% of portfolio
0.05%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$9.57 - $35.08 $24,173 - $88,612
-2,526 Reduced 12.38%
17,874 $526,000
Q2 2024

Aug 14, 2024

BUY
$12.35 - $26.11 $251,940 - $532,644
20,400 New
20,400 $251,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.02B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.